阿茲海默症 已成本港第七大致命疾病, 嘉諾撒醫院早前推出認知障礙症篩查計劃，有近 90 名 50 歲以上市民參與。篩查涵蓋蒙特利爾認知評估（MoCA）測試及 p-tau217 血液檢測。 篩查結果顯示, 四成為首次求診者，多已處於輕度或中度認知障礙。血液檢測結果顯示，近半參加者顯示存在風險，雖然其中約 66% 在 MoCA 仍屬正常。老人科專科勞思傑醫生指出，MoCA 數據反映部分患者被延遲診斷，需盡快接受進一步檢查及治療，以免病情惡化；而血液檢測能反映參加者在認知功能未明顯下降前，血液檢測已能提前識別高風險個案。本院同時在探討針對澱粉樣蛋白斑塊的抗澱粉樣蛋白藥物在清除腦內斑塊以延緩病程效用，為「及早診、及早治、及早防」提供新方向。   查詢請致電 2522 2181 或電郵 enquiry@canossahospital.org.hk。   新聞連結： am730：血液檢測 揪認知障礙隱性高危者 東網：血液檢測揭示高危群組　有助揪出早期阿茲海默症 東周刊：血液檢測揭認知障礙隱性風險 及早干預把握治療黃金時機 星島：本港認知障礙症死亡率急升 及早篩檢助病情管理 經濟TOPick：阿茲海默症居本港第七殺手病 　醫生籲市民及早篩查早診早治 晴報：配合血液檢測 助揭開認知障礙早期面紗 醫學界籲高風險人士應及早接受篩查  

Gamma Knife Centre Open Day and Information Showcase Date:        November 1, 2025 (Saturday) Time:        10:30 AM to 4:00 PM Location: Gamma Knife Centre - Basement 1, Canossa Hospital   For more event details, please visit:  https://www.facebook.com/share/p/176U512xA9/   Pre-register now: https://forms.gle/9cN98HS9zZwH55ez9   For inquiries: WhatsApp 6280 2752 or email: info@gammaknifecharitablefund.hk

  Alzheimer's Disease is "predictable" | Blood screening helps early diagnosis and treatment | "Anti-amyloid drugs" delay the deterioration of the disease from the source | Canossa Hospital provides a subsidized screening program and provides one-stop diagnosis and treatment services   As individuals age, the risk of developing dementia increases, with Alzheimer’s disease being the most common manifestation. The progression of this condition can result in significant challenges and serious implications for affected individuals and their families. Recently, there have been significant advancements in both screening and treatment, allowing for earlier detection and intervention. Canossa Hospital has unveiled an innovative blood test technology capable of identifying individuals at risk for Alzheimer's disease even before symptoms emerge, marking a significant step forward in early diagnosis and care. Additionally, the hospital has implemented a subsidized screening initiative, which features a discounted revolutionary blood test and a complimentary "Montreal Cognitive Assessment," aimed at offering comprehensive medical services from diagnosis to treatment.   Subsidized screening programme details    Chinese news links: am730: 阿茲海默症  早期治療延緩退化 東方日報: 阿茲海默症易錯過治療機會　及早篩查治療有助維持認知能力 星島日報: 新型血液檢查 及早發現早期阿茲海默症患者 經濟日報: 阿茲海默症可及早發現　新型血液檢測偵查高危人士 HK01: 60歲男患輕度認知障礙 接受抗類澱粉蛋白藥物 如常工作旅行 U港生活: 血液檢測新突破：及早發現阿茲海默症，抗類澱粉蛋白藥物延緩腦退化